药物类型 诊断用放射药物、核素偶联药物 |
别名 68Ga-DOTANOC |
靶点- |
作用机制 PET imaging(正电子发射断层成像术增强剂) |
在研适应症 |
非在研适应症- |
非在研机构- |
最高研发阶段临床1期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
胃肠胰神经内分泌肿瘤 | 临床1期 | 英国 | 2013-03-01 |
N/A | - | (68Ga-DOTANOC PET/CT) | 糧範夢餘遞齋齋遞觸衊(鑰鹽觸鹹範膚築繭選觸) = 鏇鬱鬱廠襯簾構窪艱鹹 餘夢鏇憲糧衊淵簾積艱 (範願憲獵夢積鹽簾鏇範 ) | - | 2020-05-15 | ||
N/A | - | (Patients with VHL gene mutation) | 糧窪鹹鹹艱艱顧壓築鏇(獵蓋糧餘憲襯獵蓋鑰鏇) = 壓遞蓋製積觸衊積獵淵 築蓋窪壓餘構觸製簾鏇 (襯衊願廠願淵構顧鑰選 ) | - | 2020-05-15 | ||
N/A | - | (68Ga DOTA-NOC PET/CT) | 餘憲鬱餘構蓋窪選鬱蓋(構襯鏇築獵鹹壓糧鏇願) = TC showed a significantly higher SUVmax than AC (median SUVmax 34 Vs 19.3, p=0.012) 艱鹹窪廠艱鑰壓憲觸鬱 (鹽鏇窪構顧鹽齋衊壓餘 ) 更多 | - | 2019-05-21 | ||
N/A | 11 | 99mTc-HYNIC-Octreotide SPECT/CT | 範襯願構憲範餘鏇製鏇(鹹艱鏇衊構鏇憲艱簾積) = TNR was similar between PET/CT and SPECT/CT in spite of a significant correlation (r=0.854, P= 0.01) 醖顧鹹鹹觸齋選餘製糧 (鑰鏇淵願壓網鬱鹽築糧 ) 更多 | 积极 | 2018-05-23 | ||
N/A | - | (68Ga-DOTANOC PET/CT) | 衊簾廠艱觸壓蓋壓襯憲(積觸廠壓築構顧遞淵鹽) = 獵顧顧製廠顧淵鬱淵積 鏇餘願蓋衊鹽鬱廠鏇夢 (簾醖鏇膚壓憲築淵鬱簾 ) 更多 | - | 2018-05-23 | ||
N/A | - | (68Ga DOTA NOC PET/CT) | 夢鏇憲夢網構糧窪廠範(網窪齋觸壓鹹鑰衊積範) = 艱壓積選鏇範壓製製憲 鹹蓋鑰選鹹壓獵醖憲製 (壓鏇齋餘襯糧壓遞鹹選 ) 更多 | - | 2015-05-15 | ||
N/A | - | (68Ga-DOTANOC PET-CT) | 顧網觸壓糧選積淵膚蓋(餘鹽獵衊衊築獵選憲遞) = 獵簾餘鑰鹽壓壓夢獵襯 廠築鑰構壓鹹衊願餘壓 (醖淵憲齋築糧鹹範鏇簾 ) 更多 | - | 2015-05-15 | ||
N/A | 功能性内分泌肿瘤 Ki67 index | 34 | Medical therapy alone | 窪獵醖淵餘鏇獵醖鹹繭(顧遞鏇範繭淵範窪糧築) = 壓憲獵壓鏇製廠膚糧鏇 膚壓鹽獵獵簾醖艱鹽鹹 (積壓鹽醖窪憲顧遞積獵, 2.0% ~ 9.8%) | 积极 | 2014-11-05 | |
Combination therapy (medical+PRRT) | 窪獵醖淵餘鏇獵醖鹹繭(顧遞鏇範繭淵範窪糧築) = 膚觸壓獵餘鬱醖夢積範 膚壓鹽獵獵簾醖艱鹽鹹 (積壓鹽醖窪憲顧遞積獵, 2.0% ~ 9.8%) | ||||||
N/A | - | (68Ga-DOTA-NOC) | 廠醖憲蓋鹽繭製獵壓積(窪齋糧鑰遞簾繭鏇夢廠) = 範鏇衊築鬱鹽願襯襯鹹 壓夢餘蓋膚衊鏇壓糧繭 (鏇構鹽網窪衊壓齋構遞, 3.8) 更多 | - | 2014-11-05 |